Preparation Method Of The Solid Formulation Of Clopidogrel Bisulfate

a technology of clopidogrel and bisulfate, which is applied in the field of preparation of clopidogrel bisulfate tablets, can solve the problems of poor final product quality and sticking problem

Inactive Publication Date: 2013-01-10
SHANGHAI ANBISON LAB
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is known to one skilled in the art that the most difficult problem in preparation technology of Clopidogrel bisulfate tablets is in that the Clopidogrel bisulfate tends to adhere strongly to the punch and / or the die surfaces of a conventional tablet compression machine, causing picking, sticking or other kinds of surface irregularities on tablets, which consequently leads to poor final product quality.
The root cause is attributed to the extremely hygroscopic nature of Clopidogrel bisulfates which makes the material extremely adhesive to the metal surfaces of the punch and / or the die, and further compression between the upper / lower punch and the die causes the Clopidogrel bisulfate to rapidly form a film on the surface of the punch and die therefore cause a sticking problem.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation Method Of The Solid Formulation Of Clopidogrel Bisulfate

Examples

Experimental program
Comparison scheme
Effect test

example 1

preparing Clopidogrel Bisulfate Tablets

[0064]97.88 g Clopidogrel bisulfate was mixed with 60.0 g Lactose, 40.00 g Microsrystalline Cellulose. Adding the 10% prepared Hydroxypropyl Cellulose solution and granulation. The granules were dried and screening. Blending with 26.00 g Microcrystalline Cellulose, 6.00 g Crospovidone, 17.00 g of Hydrogenated Vegetable Oil and Sodium Lauryl Sulphate and compression. The tablet weight is 250 mg with diameter 9 mm.

example 2

[0065]97.88 g Clopidogrel bisulfate was mixed with 60.00 g Lactose, 40 g of Microcrystalline Cellulose. Adding the 10% prepared Hydroxypropyl Cellulose solution and granulation. The granules were dried and blended with Aerosil (1.5 g, the weight equivalent to 0.6% of tablet weight), Microcrystalline Cellulose 26.00 g, Crospovidone 6.00 g, 17.00 g Hydrogenated Vegetable Oil and Sodium Lauryl Sulphate. Then compression with tablet weight 250 mg and diameter 9 mm.

example 3

[0066]97.88 g Clopidogrel bisulfate was premixed with Aerosil, (0.75 g, equivalent to 0.3% of tablet weight), then mixed with Lactose 60.00 g, Microcrystalline Cellulose 40.00 g. Adding the 10% prepared Hydroxypropyl Cellulose solution to and granulation. The granules were dried and blended with Microcrystalline Cellulose 26.00 g, Crospovidone 6.00 g, 17.00 g Hydrogenated Vegetable Oil and Sodium Lauryl Sulphate. Then compression with tablet weight 250 mg with diameter 9 mm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
specific surface areaaaaaaaaaaa
Login to view more

Abstract

A solid formulation of clopidogrel bisulfate and its preparation method are disclosed. The formulation comprises clopidogrel bisulfate as active ingredient, colloidal silicon dioxide as anti-adherent/coating and the carriers selected from diluent, binder, glidant, disintegrant and/or lubricant.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application is a continuation of pending International patent application PCT / CN2010 / 073879 filed on Jun. 12, 2010 which designates the United States and claims priority from Chinese patent application 201010106188.X filed on Feb. 5, 2010. The content of all prior applications is incorporated herein by reference.FIELD OF THE INVENTION[0002]This invention relates to a method of preparation of Clopidogrel bisulfate tablets.BACKGROUND OF THE INVENTION[0003]Chemically Clopidogrel bisulfate is methyl(+)-(S)-α(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate sulfate (1:1).[0004]One of Clopidogrel bisulfate structural formula is as follows:[0005]Clopidogrel bisulfate is an inhibitor of ADP-induced platelet aggregation acting by direct inhibition of adenosine diphosphate (ADP) binding to its receptor and of the subsequent ADP-mediated activation of the glycoprotein GPIIb / IIIa complex. In addition to ADP, Clopidogrel also...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/14A61K9/20A61P7/02A61K31/4365
CPCA61K31/4365A61K9/20A61K9/2095A61P7/02A61K9/2009
Inventor LEI, JIFENGSHA, PINGJIN, RONGGENSHI, YUWENSHEN, XINHUA
Owner SHANGHAI ANBISON LAB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap